Back to Search
RACHEL HERBST, PHD
PHD
Clinical Child & Adolescent Psychologist
NPI: 1366707366Individual
Specialties, Licenses & Credentials
Clinical Child & Adolescent PsychologistPrimary
Psychologist — Clinical Child & Adolescent
Code: 103TC2200X
7385(OH)
Research & Publications (20)
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
PMID 19546406·J Clin Oncol·2009
3-trial
Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy.
PMID 18787840·J Cancer Res Clin Oncol·2009
8-other
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
PMID 19404214·J Thorac Oncol·2009
3-trial
Substituted benzimidazoles: A novel chemotype for small molecule hKSP inhibitors.
PMID 19481450·Bioorg Med Chem Lett·2009
7-preclinical
Targeted drug delivery strategies to treat lung metastasis.
PMID 19663628·Expert Opin Drug Deliv·2009
6-review
Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.
PMID 18556142·Int J Radiat Oncol Biol Phys·2009
3-trial
Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing.
PMID 19221030·Proc Natl Acad Sci U S A·2009
7-preclinical
[Greasy, sticky flakes from an uninflamed scalp in children?].
PMID 19402336·Med Monatsschr Pharm·2009
8-other
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
PMID 19447868·Clin Cancer Res·2009
8-other
Cetuximab therapy for patients with advanced squamous cell carcinomas of the head and neck.
PMID 19190590·Nat Clin Pract Oncol·2009
8-other
Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium.
PMID 19550249·J Thorac Oncol·2009
8-other
CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignancies.
PMID 19188153·Clin Cancer Res·2009
4-observational
Role of conserved tyrosine residues in NiSOD catalysis: a case of convergent evolution.
PMID 19183068·Biochemistry·2009
8-other
The changing face of phase 1 cancer clinical trials: new challenges in study requirements.
PMID 19165808·Cancer·2009
4-observational
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.
PMID 19208430·Cancer·2009
3-trial
Beyond doublet chemotherapy for advanced non-small-cell lung cancer: combination of targeted agents with first-line chemotherapy.
PMID 19289368·Clin Lung Cancer·2009
6-review
Aberrant development of neuromuscular junctions in glycosylation-defective Large(myd) mice.
PMID 19346129·Neuromuscul Disord·2009
7-preclinical
Kinesin motor proteins as targets for cancer therapy.
PMID 19156502·Cancer Metastasis Rev·2009
6-review
Bevacizumab/chemotherapy in non-small-cell lung cancer: looking for a few good men?
PMID 18501092·Clin Lung Cancer·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3333 BURNET AVE, ML 3015
CINCINNATI, OH 45229 - Phone
- (513) 636-4336
Quick Facts
- NPI
- 1366707366
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile